Search results

In partnership with the Australian Museum as part of National Science Week explore the 2020 hackathon theme of Deep Blue: Innovation for the future of our oceans

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

ANSTO and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have been recognised for their valuable contributions to the search and recovery efforts for a missing 8mm-long radioactive capsule in the Western Australian outback.

The Australian Academy of Technology and Engineering (ATSE) has elected Professor Andrew Peele, Director of ANSTO’s Australian Synchrotron, to become a Fellow of the prestigious organisation.

This program explores the mechanism and outcome of the interaction of radiation on biological systems in order to improve our understanding of the impact of radiation on the brain, optimise radiotherapy and develop mitigation strategies for space travellers.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

An international collaboration led by The University of Sydney and supported by ANSTO has developed an advanced, innovative artificial intelligence application that could be used to help examine tissue samples and identify signs of disease/

The mechanical, electrical, chemical, optical and thermal properties of glass, as determined by its chemical composition and atomic structure, make it a highly useful material with a myriad of applications.

Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.

ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.

The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.